Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

Y K Lyauk; C Stage; T K Bergmann; L Ferrero-Milliani; D Bjerre; R Thomsen; Kim Peder Dalhoff; H.B. Rasmussen; G. Jürgens

doi:10.1111/cts.12423

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

Y K Lyauk, C Stage, T K Bergmann, L Ferrero-Milliani, D Bjerre, R Thomsen, Kim Peder Dalhoff, H.B. Rasmussen, G. Jürgens

Research output: Contribution to journal › Journal article › Research › peer-review

161 Downloads (Pure)

Abstract

The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.

Original language	English
Journal	Clinical and Translational Science
Volume	9
Issue number	6
Pages (from-to)	337-345
ISSN	1752-8062
DOIs	https://doi.org/10.1111/cts.12423
Publication status	Published - 2016

Documents & Links

10.1111/cts.12423Licence: CC BY-NC

Population Pharmacokinetics of MethylphenidateFinal published version, 667 KBLicence: CC BY-NC

Cite this

Lyauk, Y. K., Stage, C., Bergmann, T. K., Ferrero-Milliani, L., Bjerre, D., Thomsen, R., Dalhoff, K. P., Rasmussen, H. B., & Jürgens, G. (2016). Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. Clinical and Translational Science, 9(6), 337-345. https://doi.org/10.1111/cts.12423

@article{98662450930f4a1190f6f429be907b5d,

title = "Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants",

abstract = "The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.",

author = "Lyauk, {Y K} and C Stage and Bergmann, {T K} and L Ferrero-Milliani and D Bjerre and R Thomsen and Dalhoff, {Kim Peder} and H.B. Rasmussen and G. J{\"u}rgens",

note = "{\textcopyright} 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.",

year = "2016",

doi = "10.1111/cts.12423",

language = "English",

volume = "9",

pages = "337--345",

journal = "Clinical and Translational Science",

issn = "1752-8062",

publisher = "Wiley",

number = "6",

}

Lyauk, YK, Stage, C, Bergmann, TK, Ferrero-Milliani, L, Bjerre, D, Thomsen, R, Dalhoff, KP, Rasmussen, HB & Jürgens, G 2016, 'Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants', Clinical and Translational Science, vol. 9, no. 6, pp. 337-345. https://doi.org/10.1111/cts.12423

TY - JOUR

T1 - Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

AU - Lyauk, Y K

AU - Stage, C

AU - Bergmann, T K

AU - Ferrero-Milliani, L

AU - Bjerre, D

AU - Thomsen, R

AU - Dalhoff, Kim Peder

AU - Rasmussen, H.B.

AU - Jürgens, G.

PY - 2016

Y1 - 2016

N2 - The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.

AB - The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.

U2 - 10.1111/cts.12423

DO - 10.1111/cts.12423

M3 - Journal article

C2 - 27754602

SN - 1752-8062

VL - 9

SP - 337

EP - 345

JO - Clinical and Translational Science

JF - Clinical and Translational Science

IS - 6

ER -

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

Abstract

Documents & Links

Fingerprint

Cite this